PRCT Q4 2022 Earnings — PROCEPT BioRobotics Corporation Revenue & Financial Results | Market Cap Arena

PRCTPROCEPT BioRobotics Corporation

$1B

Q4 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$24M+134.5% YoY

Gross Profit

$11M44.9% margin

Operating Income

-$25M-105.3% margin

Net Income

-$28M-118.5% margin

EPS (Diluted)

$-0.63

QoQ Revenue Growth

+16.8%

Cash Flow

Operating Cash Flow

-$25M

Free Cash Flow

-$26M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$309M

Total Liabilities

$112M

Stockholders' Equity

$197M

Cash & Equivalents

$223M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$24M	$10M	+134.5%
Gross Profit	$11M	$5M	+136.4%
Operating Income	-$25M	-$17M	-48.8%
Net Income	-$28M	-$18M	-53.5%

Geographic Segments

UNITED STATES

$10M92%

Outside the United States

$848,0008%